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ABSTRACT Missense mutations in the membrane-binding actin-based motor protein, myosin-1a (Myo1a), have recently been
linked to sensorineural deafness in humans. One of these mutations, E385D, impacts a residue in the switch II region of the
motor domain that is present in virtually all members of the myosin superfamily. We sought to examine the impact of E385D on
the function of Myo1a, both in terms of mechanochemical activity and ability to target to actin-rich microvilli in polarized epithelial
cells. While E385D-Myo1a demonstrated actin-activated ATPase activity, the VMAX was reduced threefold relative to wild-type.
Despite maintaining an active mechanochemical cycle, E385D-Myo1a was unable to move actin in the sliding ﬁlament assay.
Intriguingly, when an enhanced-green-ﬂuorescent-protein-tagged form of E385D-Myo1a was stably expressed in polarized
epithelial cells, this mutation abolished the microvillar targeting normally demonstrated by wild-type Myo1a. Notably, these data
are the ﬁrst to suggest that mechanical activity is essential for proper localization of Myo1a in microvilli. These studies also
provide a unique example of how even themost mild substitution of invariant switch II residues can effectively uncouple enzymatic
and mechanical activity of the myosin motor domain.
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Class I myosins are monomeric actin-based motors with
the ability to interact directly with cellular membranes by
virtue of highly basic regions in their C-terminal tail domains.
Myo1a was one of the ﬁrst vertebrate class I myosins dis-
covered over 20 years ago when it was identiﬁed as a major
component of the enterocyte brush border (BB) cytoskeleton
(1). Although cell biological studies initially indicated that
Myo1a expression was restricted to the intestinal tract (2),
recent reports have demonstrated that Myo1a transcripts are
present in mouse inner ear (3,4), and that mutations inMyo1a
are linked to autosomal dominant nonsyndromic deafness
(NSD) in humans (4). In a genetic screen of individuals with
deafness thatmapped to locusDFNA48, but not yet linked to a
speciﬁc gene, eight families were found to harbor mutations
inMyo1a (R93X, 116insS, V306M, E385D, G662E, G674D,
S797F, S910P) (4). Although this large cluster of mutations
suggests that Myo1a may be a leading contributor to NSD,
the role of Myo1a in the inner ear and the impact of NSD
mutations on Myo1a function remain uncharacterized.
The goal of this study was to investigate the impact of
the E385D mutation on the enzymatic and motor function of
Myo1a. This substitution impacts an invariant glutamate in
the active site (Fig. 1 A) and is associated with moderate-
to-severe hearing loss with an early onset (4). To investigate
the impact of E385D on Myo1a function, we produced wild-
type (WT-Myo1a) and mutant (E385D-Myo1a) forms of full-
length humanMyo1a using a baculovirus/SF9 cell expression
system. Both Myo1a variants were tagged with C-terminal
tandem MYC-FLAG epitopes to facilitate puriﬁcation and
immobilization in motility assays. SDS-PAGE analysis showed
that Myo1a migrated at the proper molecular weight,
copuriﬁed with calmodulin, and was .95% pure based on
Coomassie blue staining. As a ﬁrst step in our functional
analysis, we investigated the actin-activated ATPase activity
of mutant and WT-Myo1a. E385D-Myo1a hydrolyzed ATP
in an actin-dependent manner (VMax¼ 0.196 0.01 s1,KM¼
17.06 1.0mM)albeit at a reduced rate relative toWT (VMax¼
0.606 0.05 s1,KM¼ 24.06 6.0mM) (Fig. 2; data represent
three preparations). The basal rates measured in this assay
were similar (;0.03–0.05 s1). Actin cosedimentation assays
demonstrated that E385D- and WT-Myo1a both have a
low afﬁnity for actin (KActin ¼ 42 6 5 and 73 6 9 mM,
respectively) in the presence of ATP (data not shown),
suggesting E385D-Myo1a dissociates from actin in an ATP-
dependent manner. Although these measurements demon-
strate that E385D-Myo1amaintains a compromised yet active
enzymatic cycle, we sought to determine the impact of this
mutation on Myo1a mechanical activity. To this end, we
measured the velocities produced by WT and E385D-Myo1a
using a sliding ﬁlament assay. Before each assay, noncycling
motors (‘‘dead-heads’’) were cleared from our preparations
by ultracentrifugation in the presence of F-actin and ATP. In
agreement with earlier studies (5),WT-Myo1amoved actin at
28.0 6 1.0 nm/s at 23C (mean 6 SE, 66 ﬁlaments scored
from three preparations; see inset, Fig. 3 A). Strikingly, the
E385D mutation abolished actin movement. Coverslips
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coated with the mutant bound ﬁlaments at densities compa-
rable to WT-Myo1a, yet ﬁlaments failed to undergo directed
movement (Fig. 3 B). Although it remains possible that
E385D-Myo1a moves actin at some exceedingly slow
velocity, the speed would need to be at least 100-fold slower
than WT to appear nonmotile on the timescale of our
observations. Thus, these data indicate that E385D effectively
uncouples the enzymatic andmechanical activities ofMyo1a.
To understand how uncoupling mechanochemistry might
inﬂuence the behavior of Myo1a in a cellular context, we
expressed enhanced green ﬂuorescent protein (EGFP)-
tagged WT and E385-Myo1a variants in LLC-PK1-CL4
(CL4) cells. CL4 cells express a prominent apical brush
border and form unique ‘‘cysts’’ that enable the observation
of microvilli in a plane parallel to the image plane of the
microscope (Fig. 4, A–C). Consistent with our previous
studies (6), confocal microscopy revealed clear enrichment
of EGFP-WT-Myo1a at the periphery of the cell in apical
microvilli (arrows, Fig. 4 B). In contrast, EGFP-E385D-
Myo1a demonstrated high cytosolic levels with ﬂuorescence
comparable to the cell periphery (compare asterisk with
arrows, Fig. 4 C). The localization of EGFP-E385D-Myo1a
was similar to EGFP alone (Fig. 4 A), indicating that this
mutation disrupts the ability of Myo1a to localize to micro-
villi at the cell periphery.
E385 resides in a highly conserved region of the motor
domain active site known as switch II (equivalent residue in
Dictyostelium myosin-II is E459; Fig. 1, A and B) (7), where
it may play a role in coordinating the water molecule that
attacks the g-phosphate during ATP hydrolysis (8). Indeed,
structures of the myosin II motor domain crystallized with
different nucleotide analogs reveal that the switch II region
undergoes a large conformational change (.3 A˚) between
the ATP and transition state structures (8,9) (Fig. 1 B).
During the transition state, E385 may also interact with R158
of switch I (equivalent residue in Dictyostelium myosin II is
R238). This interaction may form a salt bridge that, along
with the P-loop, constitutes the active site ‘‘backdoor’’ (Fig.
1 B), a structure believed to govern the rate of phosphate
release following hydrolysis (10). Intriguingly, molecular
modeling predicts that an aspartate at position 385 would be
unable to form the backdoor salt bridge due to its shorter
side chain (Fig. 1 B). Thus, whereas an E/D substitution
would normally be considered a mild perturbation, the
FIGURE 1 (A) Ribbon cartoon of the Dictyostelium myosin II
motor domain showing the residue equivalent to Myo1a E385
relative to key structural elements of the active site. (B) Struc-
tural models of switch I and II in the ATP bound (Mg-ADP-BeFx)
and transition state (Mg-ADP-VO4) show that the backdoor salt
bridge (purple) may be disrupted in E385D. Modeling and bond
detection (threshold of 3.3 A˚) performed with DeepView v3.7.
Myo1a residue numbers are shown.
FIGURE 2 Actin-activated ATPase activity of WT and E385D
Myo1a. Solid lines show the ﬁt to a Michaelis-Menten model.
FIGURE 3 (A) Overlay of ﬂuorescent actin ﬁlaments imaged
during a sliding ﬁlament assay with WT-Myo1a. Red represents
ﬁlaments at t5 0, whereas green shows the state of each ﬁlament
310 s later. (B) E385D-Myo1a fails to produce actin sliding, result-
ing in near perfect overlap (yellow) in time shifted images. Bars
are 10 mm in panels A and B.
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critical location of this residue may explain its ability to
uncouple the enzymatic and mechanical activity of Myo1a.
Indeed, previous studies on S456L, a switch II mutation in
Dictyostelium myosin II, also described a mechanochemical
uncoupling phenotype (11).
The mislocalization of E385D-Myo1a suggests that motor
domain mechanical activity is required for targeting WT-
Myo1a to microvilli. Intriguingly, these data appear to
conﬂict with a previous study showing that the sole class
I myosin from Aspergillus is able to fulﬁll essential cellular
functions in the absence of enzymatic and mechanical ac-
tivity (12). However, our new results are consistent with other
work that highlights the signiﬁcance of the motor domain in
the subcellular targeting of class I myosins (13,14). Because
our previous studies have also shown that the C-terminal tail
is important for Myo1a localization (6), future studies must
investigate how motor and tail domains cooperate to control
subcellular localization.
These studies are the ﬁrst to examine the impact of a
human deafness mutation on the function of Myo1a. These
results provide us with information on the molecular level
defects that give rise to deafness in humans afﬂicted with the
E385D mutation. Although the precise role of Myo1a within
the inner ear is not clear, studies on the enterocyte brush
border enable us to speculate that Myo1a is likely expressed
in hair cells, which possess actin-rich stereocilia on their
apex. Here, Myo1a may play a role in stabilizing apical
membrane-cytoskeleton interactions, engage in intrastereo-
ciliar transport of membrane proteins or lipids, or power the
shedding of apical membrane from stereocilia tips (15).
Future studies must focus on elucidating the role of Myo1a
in the context of the inner ear, as well as exploring the
transient kinetic details that give rise to the mechanochem-
ical uncoupling phenotype described here.
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FIGURE 4 Expression of EGFP (A), EGFP-Myo1a (B), or EGFP-
E385D-Myo1a (C) in CL4 cells. Images on the left show the EGFP
signal alone; images on the right show the merge of EGFP
(green) with phalloidin (red) and DAPI (blue) to visualize F-actin
and nuclei, respectively. Bars are 20 mm in panels A–C. Images
are representative of the localization observed in two indepen-
dently derived stable lines for each construct.
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